How safe is it for you to get the Covishield vaccine? Does it protect you against all variants of COVID-19?
Covishield is a COVID-19 vaccine developed by Oxford University & AstraZeneca, which is a British-Swedish company. In India, the vaccine was developed by the Serum Institute India in partnership with the previously mentioned companies. In January 2021, when the COVID vaccination drive started in India, only two vaccines were initially approved by India’s drug regulators, Covishield and Covaxin.
To stand behind their product, the CEO of the Serum Institute India Mr. Adar Poonawala, took the first dose of the Covishield vaccine on the first day of India’s COVID-19 vaccination drive. Since then, Covishield has become popular among the masses, with people waiting for Covishield to be restocked at vaccination centres instead of getting vaccinated with the other available vaccines, potentially risking their well-being in order to choose Covishield over other vaccines.
However, there are some issues with Covishield, with reports of people losing their lives over the side effects of the vaccine in various parts of the world. As experts are suggesting that vaccines might become less effective given the new mutations/variants of COVID that are presenting themselves regularly, how safe are you from COVID-19 after being fully vaccinated using Covishield? Let’s learn more about the efficacy of Covishield against the various variants of COVID-19.
How Effective Is Covishield Against The Various Variants Of COVID-19?
Even though vaccines are used to make people immune to any disease, the COVID-19 vaccines, none of them are currently able to provide 100% immunity against the virus. One of the main reasons for that is the virus is ever-evolving, and because of that, the vaccine’s efficacy drops when the virus mutates and becomes more resilient and transmissible.
One of the best parts about Covishield is that the efficacy of this vaccine does not vary in terms of its effectiveness against the different variants of COVID-19. As of now, the reported data suggests that Covishield is 63% effective against COVID-19 for the SARS CoV 2 and delta variant of the virus. The efficacy data against the Omicron variant of the virus have not been released yet because it is quite new as of yet, and trials and test results have not been released yet.
According to the WHO, any COVID vaccine with an efficacy rate above 50% can be used to control and limit the spread of the pandemic and eventually end the pandemic overall. The efficacy rate mentioned above for Covishield is only for its ability to make the masses immune to the virus. This means that after getting fully vaccinated with Covishield, you become 63% immune to COVID-19. However, as COVID vaccines are not currently able to provide 100% immunity against the virus, it works by improving your body’s ability to cope with COVID infections and reducing the possibility of you developing advanced COVID infections.
Covishield has an efficacy rate of 85% in reducing the possibility of you developing severe or advanced cases of COVID-19. Currently, the goal of vaccination is to improve the mortality rate of COVID-19 and Covishield works great mainly because the protection of Covishield does not vary according to the different variants of COVID, as per current reports in 2022.
Final Thoughts
According to reports, 88% of all COVID vaccines administered in India have been Covishield. The outpouring of support for this vaccine shows how much it has been able to make the masses feel safer about vaccination. Regardless of its side effects, Covishield remains the most popular COVID vaccine in India. With the booster dose announced in January 2022, there is no surprise that this vaccine will continue to be popular among Indians.
If you are looking for the best COVID vaccination service in Jodhpur Rajasthan, please be sure to visit Medipulse hospital. For more information about their vaccination program, visit the hospital website.